STAT+: The unexpected alliance lobbying for Medicare to pay for new obesity drugs
WASHINGTON — It’s not every day that the pharmaceutical industry, the NAACP, a cancer center, and a nonpartisan think tank are all lobbying to achieve the same policy goal.
But an effort to expand Medicare coverage for obesity drugs has managed to unite them all, and many more groups across the health care industry, too.
Continue to STAT+ to read the full story…
